Application
Immunohistochemical analysis of paraffin-embedded human brain tissue using CNOT2 (Phospho-Ser101) antibody (left) or the same antibody preincubated with blocking peptide (right).| Product Name | CNOT2 (phospho Ser101) Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | NOT2H, CDC36, CNOT2, HSPC131 |
| Product description | The CCR4-NOT complex functions as general transcription regulation complex. Subunit of the CCR4-NOT core complex that contains CHAF1A, CHAF1B, CNOT1, CNOT2, CNOT3, CNOT4, CNOT6 and CNOT8. 5 isoforms of the human protein are produced by alternative splicing.1) Albert T.K., Nucleic Acids Res. 28:809-817(2000). |
| Immunogen | CNOT2 (phospho Ser101) antibody was raised against a peptide sequence around phosphorylation site of Serine101 (S-L-S (p)-Q-G) derived from Human CNOT2. |
| Modification | p-Ser101 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC |
| IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | CNOT2 |
|---|---|
| Alternative Names | NOT2H CDC36 CNOT2 HSPC131 |
| Molecular Weight(MW) | 59 kDa |
| Tissue Specificity | The antibody detects endogenous levels of CNOT2 only when phosphorylated at serine 101. |
| Entrez Gene | 4848 |
|---|---|
| Protein Accession | NP_001186231.1 |
Application
Immunohistochemical analysis of paraffin-embedded human brain tissue using CNOT2 (Phospho-Ser101) antibody (left) or the same antibody preincubated with blocking peptide (right).| Application Notes | IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store antibody at -20˚C for up to one year. |
| Storage Buffer | Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
